Ribupatide trials for Obesity

All Ribupatide trials · All Obesity trials

Phase breakdown

Recruiting trials studying Ribupatide for Obesity

• Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
  NCT07284979 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 59 locations
• Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
  NCT07284901 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 167 locations
• Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
  NCT07284875 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 104 locations

Common questions

How many trials study Ribupatide for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.